Remdesivir, on the road to DisCoVeRy

Lancet Infect Dis. 2022 Feb;22(2):153-155. doi: 10.1016/S1473-3099(21)00559-4. Epub 2021 Sep 14.

Authors

Iwein Gyselinck¹, Wim Janssens²

Affiliations

¹ Respiratory Diseases, University Hospitals Leuven, BREATHE Research Group, Department CHROMETA, KU Leuven, 3000 Leuven, Belgium. Electronic address: iwein.gyselinck@kuleuven.be.
² Respiratory Diseases, University Hospitals Leuven, BREATHE Research Group, Department CHROMETA, KU Leuven, 3000 Leuven, Belgium.

No abstract available

Publication types

Comment

MeSH terms

Adenosine Monophosphate / analogs & derivatives
Adenosine Monophosphate / therapeutic use
Alanine* / analogs & derivatives
Alanine* / therapeutic use
Humans

Substances

remdesivir
Adenosine Monophosphate
Alanine